Drugs / Mycobacterium bovis bacillus Calmette-Guérin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00749034 Comparator | Sep 2008 → Dec 2009 | tuberculosis | Serum Life Science Europe GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mycobacterium bovis bacillus Calmette-Guérin | “Current vaccination using Mycobacterium bovis bacillus Calmette-Guérin (BCG)” PMID 23290835 ↗ Jan 2013 |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00749034 ↗ |
| Modality | Vaccine | “Current vaccination using Mycobacterium bovis bacillus Calmette-Guérin (BCG)” PMID 23290835 ↗ Jan 2013 |